Ameresco Forms $1.8B Biogas Joint Venture with HASI, Securing $400M Investment and Updating Guidance

summarizeSummary

Ameresco has formed a significant joint venture, Neogenyx Fuels, with HASI, securing a $400 million investment for its biogas business and updating its financial guidance, while also reporting a Q1 EPS miss.

check_boxKey Events

• Strategic Joint Venture Formed

  Ameresco (70% ownership) and HA Sustainable Infrastructure Capital, Inc. (HASI, 30% ownership) have formed Neogenyx Fuels LLC, a new joint venture for Ameresco's biogas business, with a post-money enterprise value of $1.8 billion.

• Significant Capital Infusion

  HASI will invest $400 million into Neogenyx Fuels, with $100 million paid directly to Ameresco for its existing biogas business and approximately $58 million used to reduce an existing loan balance. The remaining funds will support the JV's growth.

• Q1 2026 Financial Results Reported

  Ameresco reported Q1 2026 revenues of $401.5 million (up 14% year-over-year), a net loss attributable to common shareholders of $18.3 million (GAAP EPS of -$0.35, Non-GAAP EPS of -$0.33), and Adjusted EBITDA of $40.5 million.

• FY 2026 Guidance Updated

  The company updated its full-year 2026 guidance to reflect the Neogenyx Fuels transaction, maintaining revenue guidance but adjusting Adjusted EBITDA and Non-GAAP EPS downwards due to the 30% non-controlling interest.

auto_awesomeAnalysis

Ameresco has entered into a material definitive agreement to form Neogenyx Fuels, a joint venture with HA Sustainable Infrastructure Capital, Inc. (HASI), valued at a post-money enterprise of $1.8 billion. This strategic move addresses Ameresco's capital needs and unlocks significant value in its biogas business, providing $100 million in direct cash to Ameresco and additional funding for the JV's growth. Given the company's previous financial baseline, which included negative operating cash flow and increased debt, this capital infusion and strategic partnership are highly positive for long-term stability and growth. While the company reported a Q1 EPS miss and adjusted its full-year guidance due to the JV's non-controlling interest, the underlying revenue guidance remains unchanged, indicating the strategic benefits outweigh the short-term earnings adjustments. The transition of a key executive to lead the new JV further underscores the strategic importance of this initiative.